ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy

Abramson Cancer Center at Penn Medicine

Status and phase: Enrolling; Phase 2

Conditions: Gastrointestinal Cancer; Lung Cancer; Head and Neck Cancer

Treatments: Device: ChatBot

Study type: Interventional

Funder types: Other

Identifiers

NCT05318027

UPCC 18921

Details and patient eligibility

About

Evaluate the feasibility of using a chatbot combined with continuous activity monitoring to proactively identify, appropriately triage and help manage patients' symptoms during cancer treatment Determine whether such an early outpatient clinic-based intervention can decrease rates of excess triage visits

Correlate changes in activity and early symptom management to emergency department visits, unplanned inpatient hospitalizations and treatment breaks

Enrollment: 70 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults (age >18 years) with a diagnosis of a head and neck, lung, gastrointestinal cancer, that are receiving concurrent chemotherapy and radiation treatment.
• Possession of a mobile device that can receive SMS texts and can deliver FitBit data wirelessly
• Ability read and respond in English
• Ability to provide informed consent to participate in the study

Exclusion criteria

• Patients who are bed bound at baseline (ECOG 4)
• Patients who rely on a wheelchair for ambulation

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

70 participants in 2 patient groups

Activity Monitoring and ChatBot

Experimental group

Description:

Patients will receive standard of care chemotherapy and radiation therapy regimens, activity monitoring and utilize a ChatBot

Treatment:

Device: ChatBot

Activity Monitoring without ChatBot

No Intervention group

Description:

Patients will receive standard of care chemotherapy and radiation therapy regimens, activity monitoring alone